Cargando…

Mitochondrial dysfunction in pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is characterized by the increased pulmonary vascular resistance due to pulmonary vasoconstriction and vascular remodeling. PAH has high disability, high mortality and poor prognosis, which is becoming a more common global health issue. There is currently no drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Weiwei, Liu, Bo, Wang, Yazhou, Zhang, Hengli, He, Lang, Wang, Pan, Dong, Mingqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795033/ https://www.ncbi.nlm.nih.gov/pubmed/36589421 http://dx.doi.org/10.3389/fphys.2022.1079989

Ejemplares similares

Mitochondrial dysfunction in vascular endothelial cells and its role in atherosclerosis
por: Qu, Kai, et al.
Publicado: (2022)

Skeletal muscle dysfunctions in pulmonary arterial hypertension: Effects of aerobic exercise training
por: Drummond, Filipe Rios, et al.
Publicado: (2023)

Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?
por: Li, Ke-Xue, et al.
Publicado: (2022)

Nanotherapeutics for Treatment of Pulmonary Arterial Hypertension
por: Segura-Ibarra, Victor, et al.
Publicado: (2018)

Pulmonary Arterial Hypertension: Iron Matters
por: Ramakrishnan, Latha, et al.
Publicado: (2018)

Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension
por: Forouzan, Omid, et al.
Publicado: (2019)

Pulmonary Arterial Remodeling Is Related to the Risk Stratification and Right Ventricular-Pulmonary Arterial Coupling in Patients With Pulmonary Arterial Hypertension
por: Grignola, Juan C., et al.
Publicado: (2021)

Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction
por: Karmouty-Quintana, Harry, et al.
Publicado: (2018)

Predictive Modeling of Secondary Pulmonary Hypertension in Left Ventricular Diastolic Dysfunction
por: Harrod, Karlyn K., et al.
Publicado: (2021)

Crocetin Attenuates Sepsis-Induced Cardiac Dysfunction via Regulation of Inflammatory Response and Mitochondrial Function
por: Wang, Yanpeng, et al.
Publicado: (2020)

Increased Drp1-Mediated Mitochondrial Fission Promotes Proliferation and Collagen Production by Right Ventricular Fibroblasts in Experimental Pulmonary Arterial Hypertension
por: Tian, Lian, et al.
Publicado: (2018)

Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy
por: Lyle, Melissa A., et al.
Publicado: (2017)

Data-driven computational models of ventricular-arterial hemodynamics in pediatric pulmonary arterial hypertension
por: Tossas-Betancourt, Christopher, et al.
Publicado: (2022)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)

Mitochondrial dysfunction in cardiovascular disease: Towards exercise regulation of mitochondrial function
por: Li, Kunzhe, et al.
Publicado: (2023)

New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension
por: Hu, Liqing, et al.
Publicado: (2020)

Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology
por: Lee, Michael H., et al.
Publicado: (2022)

Epsin15 Homology Domains: Role in the Pathogenesis of Pulmonary Arterial Hypertension
por: Predescu, Dan, et al.
Publicado: (2018)

Current Understanding of the Right Ventricle Structure and Function in Pulmonary Arterial Hypertension
por: Sharifi Kia, Danial, et al.
Publicado: (2021)

Effects of voluntary running on the skeletal muscle of rats with pulmonary artery hypertension
por: Drummond, Filipe Rios, et al.
Publicado: (2023)

Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension
por: Yao, Xiaoting, et al.
Publicado: (2021)

Rhynchophylline Ameliorates Endothelial Dysfunction via Src-PI3K/Akt-eNOS Cascade in the Cultured Intrarenal Arteries of Spontaneous Hypertensive Rats
por: Hao, Hui-Feng, et al.
Publicado: (2017)

Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension
por: Sun, Yazhou, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Pulmonary Hypertension
por: Ryanto, Gusty Rizky Teguh, et al.
Publicado: (2023)

Piezo1, a novel therapeutic target to treat pulmonary arterial hypertension
por: Yang, Qifeng, et al.
Publicado: (2023)

Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study
por: Foris, Vasile, et al.
Publicado: (2023)

Pulmonary Artery Smooth Muscle Cell Senescence Promotes the Proliferation of PASMCs by Paracrine IL-6 in Hypoxia-Induced Pulmonary Hypertension
por: Wang, Ai-Ping, et al.
Publicado: (2021)

Association Between the Coronary Sinus Ostial Size and Atrioventricular Nodal Reentrant Tachycardia in Patients With Pulmonary Arterial Hypertension
por: Ding, Lei, et al.
Publicado: (2022)

Nitric oxide augments signaling for contraction in hypoxic pulmonary arterial smooth muscle—Implications for hypoxic pulmonary hypertension
por: Hinton, Martha, et al.
Publicado: (2023)

Editorial: Calcium and pulmonary hypertension
por: Li, Ji-Feng, et al.
Publicado: (2022)

Mitochondrial dysfunction, alternans, and arrhythmias
por: Aon, Miguel A.
Publicado: (2013)

Left-Ventricular Energetics in Pulmonary Arterial Hypertension-Induced Right-Ventricular Hypertrophic Failure
por: Han, June-Chiew, et al.
Publicado: (2018)

Tribbles Homolog 3-Mediated Vascular Insulin Resistance Contributes to Hypoxic Pulmonary Hypertension in Intermittent Hypoxia Rat Model
por: Fan, Fang, et al.
Publicado: (2020)

The Action of 2-Aminoethyldiphenyl Borinate on the Pulmonary Arterial Hypertension and Remodeling of High-Altitude Hypoxemic Lambs
por: Castillo-Galán, Sebastián, et al.
Publicado: (2022)

Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
por: Su, Kimmy, et al.
Publicado: (2013)

Mitochondrial Dysfunction and Kidney Stone Disease
por: Chaiyarit, Sakdithep, et al.
Publicado: (2020)

Asymmetric Dimethylarginine at Sea Level Is a Predictive Marker of Hypoxic Pulmonary Arterial Hypertension at High Altitude
por: Siques, Patricia, et al.
Publicado: (2019)

Contribution of oxidative stress to endothelial dysfunction in hypertension
por: Silva, Bruno R., et al.
Publicado: (2012)

Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension
por: Farha, Samar, et al.
Publicado: (2016)

The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
por: Ge, Mengyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jb71met20e6kv6gba3p4cjassr